Progress of Antiangiogenic Drug-induced Renal Injury

Abstract

With the continuous development of precision targeting medicine, antiangiogenic drugs have achieved good therapeutic effects in the treatment of advanced cancer, but renal injury and other adverse reactions often occur during the use, which reduce the quality of life of patients. This article reviews the mechanism of renal injury induced by antiangiogenic drugs and the potential relation between renal injury and prognosis.

Keywords

• antiangiogenic drugs
• adverse reaction
• renal injury
• biomarkers